<i>RAMP3</i> is a Prognostic Indicator of Liver Cancer and Might Reduce the Adverse Effect of <i>TP53</i> Mutation on Survival

Aiping Fang, Shijie Zhou, Xiaolan Su, Chuang Liu, Xiaoxin Chen, Yang Wan, Xiaohong Lei, Linshen Xie, Yiping Jia, Wen-Zhi Wang,

Future Oncology · 2018 · 23 citations · 17 references

Concepts

Abstract

AIM: To assess the prognostic value of RAMP3 expression in terms of overall survival (OS) and recurrence-free survival (RFS) in hepatocellular carcinoma (HCC) patients. MATERIALS & METHODS: Immunochemistry staining was performed to detect RAMP3 expression. Data in the Cancer Genome Atlas-Liver Hepatocellular Cancer were used for secondary analysis. RESULTS: RAMP3 expression was significantly downregulated in HCC tissues than in normal liver tissues. Increased RAMP3 expression was an independent prognostic factor of favorable OS (hazard ratio [HR]: 0.772, 95% CI: 0.689-0.864; p < 0.001) and RFS (HR = 0.719, 95% CI: 0.633-0.817; p < 0.001). High RAMP3 expression was associated with significantly better RFS in both TP53 mutant and wildtype groups. CONCLUSION: High RAMP3 RNA expression is an independent prognostic factor of favorable OS and RFS in patients with HCC.

References

17